{
    "2020-06-05": [
        [
            {
                "time": "",
                "original_text": "金域医学(603882.SH)：160.3万份股票期权行权条件已成就",
                "features": {
                    "keywords": [
                        "金域医学",
                        "股票期权",
                        "行权条件",
                        "成就"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业6月投资策略：后疫情时代 把握恢复性子行业和医药“新基建”增量赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "后疫情时代",
                        "恢复性子行业",
                        "医药新基建"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}